Literature DB >> 3262472

Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation.

J G Monroe1, S Haldar, M B Prystowsky, P Lammie.   

Abstract

While recent evidence from several laboratories has shown that interleukin-4 (IL-4) can act on a number of cells in addition to B lymphocytes, these have thus far been limited to cells of the hematopoietic lineage. Here we report that murine IL-4 promotes DNA synthesis in both primary and immortalized fibroblasts. Marked stimulation of [3H]thymidine incorporation was observed for primary skin fibroblasts or Balb/c3T3 cells stimulated with HPLC- or immunoaffinity-purified as well as recombinant IL-4. Responses to immunoaffinity and recombinant IL-4 were completely blocked with anti-IL-4 antibody. Similar dose/response relationships were observed for recombinant IL-4 on skin fibroblasts and an IL-4 responsive murine T cell tumor, suggesting that the receptors for this lymphokine on these cells is similar. Together, these results show that IL-4 can cause DNA synthesis by murine fibroblasts presumably through ligand-receptor interactions at the cell surface. Implications of these findings to inflammation during an immune response is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262472     DOI: 10.1016/0090-1229(88)90119-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  27 in total

Review 1.  Interleukin 4 in systemic sclerosis: not just an increase.

Authors:  S P Atamas; B White
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.

Authors:  A E Postlethwaite; M A Holness; H Katai; R Raghow
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis.

Authors:  Ioannis Antonopoulos; Dimitrios Daoussis; Maria-Eleni Lalioti; Theodora E Markatseli; Alexandros A Drosos; Stavros Taraviras; Andrew P Andonopoulos; Stamatis-Nick C Liossis
Journal:  Rheumatol Int       Date:  2019-06-21       Impact factor: 2.631

4.  Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases.

Authors:  H Becker; P Potyka; C Weber; K Federlin
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 5.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

Review 6.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.

Authors:  Loka R Penke; Marc Peters-Golden
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

7.  Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.

Authors:  G Famularo; A Procopio; R Giacomelli; C Danese; S Sacchetti; M A Perego; A Santoni; G Tonietti
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

8.  Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.

Authors:  A E Postlethwaite; J M Seyer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

9.  Interleukin-4 rapidly inhibits calcium transients in response to carbachol in bovine airway smooth muscle cells.

Authors:  J M Madison; M F Ethier
Journal:  Am J Respir Cell Mol Biol       Date:  2001-08       Impact factor: 6.914

10.  Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation.

Authors:  M L Estes; K Iwasaki; B S Jacobs; B P Barna
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.